Interactions on record — worth a quick check against your medications. Check your meds →
Dietary supplement

Pedi-Active Delicious Mixed Berry Flavor Ingredients & Drug Interactions

by NaturesPlus

Tablet Or Pill Category: Other Combinations
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Pedi-Active Delicious Mixed Berry Flavor is a dietary supplement by NaturesPlus with 3 active ingredients. Its ingredients are commonly taken for memory and focus, mood and mental clarity, adhd-type symptoms.Based on those ingredients, 219 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are DMAE. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Pedi-Active Delicious Mixed Berry Flavor by NaturesPlus

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 5 of its 5 active ingredients.
  • “Phosphatidylserine-rich purified Soy Lecithin concentrate” is listed as a grouped ingredient — the label gives one combined amount (100 mg) without saying how much of each component you get.

Pedi-Active contains 5 active ingredients: phosphatidylserine, DMAE (deanol), phosphatidylcholine, phosphatidylserine-rich purified soy lecithin concentrate, and cephalin. Phosphatidylserine and phosphatidylcholine are phospholipids—fatty compounds that are thought to support brain and nerve function.

DMAE is a compound believed to affect neurotransmitter levels. The product also contains inactive ingredients including fructose, stearic acid, natural berry flavors, silica, magnesium stearate, and beet juice.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Moderate

Some clinical evidence supports this product's ingredients for its stated purpose, but it isn't conclusive.

Why this rating?
  • The label markets this product for: Memory and cognitive support for active children.
  • We looked for evidence on: Memory, Cognitive function, Age-related cognitive decline, Attention deficit-hyperactivity disorder (ADHD), Pediatric brain health, Neuronutrient support.
  • The strongest evidence on file: Phosphatidylserine is rated "Possibly Effective" for Age-related cognitive decline (Natural Medicines).
  • Also on file: Phosphatidylcholine is rated "Insufficient Reliable Evidence To Rate" for Memory.
  • Also on file: Deanol is rated "Insufficient Reliable Evidence To Rate" for Attention deficit-hyperactivity disorder (ADHD), Cognitive function.

The evidence for these ingredients is mixed. Phosphatidylserine is rated possibly effective for age-related cognitive decline and Alzheimer disease, but the evidence for athletic performance, ADHD, overall cognitive function, and dementia is insufficient.

DMAE is rated likely ineffective for Alzheimer disease and tardive dyskinesia (a movement disorder), and evidence is insufficient for aging skin, athletic performance, and ADHD. Phosphatidylcholine is possibly effective for ulcerative colitis, but evidence is insufficient for fatty liver disease, alcohol-related liver disease, Alzheimer disease, and anxiety.

For most other uses, we don't have established effectiveness data in our records.

The evidence, ingredient by ingredient Deanol Lecithin Phosphatidylserine Phosphatidylcholine

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 3 of the 3 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 3 of 3.
  • General safety write-ups exist for 3 of 3.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Phosphatidylserine and phosphatidylcholine are generally well tolerated orally, though side effects can occur. Phosphatidylserine may cause flatulence, stomach upset, headache, insomnia (especially at higher doses like 600 mg), and nausea.

Phosphatidylcholine may cause bloating, diarrhea, altered taste, nausea, vomiting, and increased sweating—particularly if you take very large doses. DMAE may cause abdominal cramps, pain, diarrhea, drowsiness, nausea, or vomiting; at doses above 1000 mg daily, it has been reported to cause mood changes (depression or elevated mood) in people with psychiatric conditions, and to worsen schizophrenia symptoms.

For pregnancy: Phosphatidylserine safety data is not sufficient, so avoidance is recommended. DMAE safety is also not well studied; animal research raises concerns, so avoidance is advised.

Phosphatidylcholine contains choline, which is needed in pregnancy, but supplement safety beyond food sources isn't well established—talk with your doctor. For breastfeeding: safety data for phosphatidylserine and DMAE is unknown and avoidance is recommended; for phosphatidylcholine, there isn't enough reliable data on supplement use, so check with your healthcare provider first.

Side effects, ingredient by ingredient Deanol Lecithin Phosphatidylserine Phosphatidylcholine

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 2 of the 3 matched ingredients can interact with medications — Deanol, Phosphatidylserine.
  • The most serious interaction on file is rated Moderate.
  • For scale: 219 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Check with your doctor or pharmacist before using this product if your child takes anticholinergic drugs (for overactive bladder, muscle spasms, or other conditions) or cholinergic drugs (for myasthenia gravis or Alzheimer disease). Phosphatidylserine and DMAE can theoretically reduce how well anticholinergics work or intensify cholinergic effects.

The search tool below lets you enter your child's exact medications to see if any are affected.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

Pedi-Active is marketed to support children's cognitive function, but the evidence for most claims is limited or insufficient. Its main concern is interaction risk if your child takes anticholinergic or cholinergic medications.

Before starting this product, talk with your child's doctor or pharmacist—especially if they're on any prescription, including medications for bladder control, muscle stiffness, myasthenia gravis, or Alzheimer disease.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 3 of 5 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Oct 24, 2023.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Pedi-Active Delicious Mixed Berry Flavor, straight from the product label.

Brand NaturesPlus
Barcode (UPC) 097467030015
Net contents 120 Chewable Tablet(s)
Market status On market
Date entered into DSLD Oct 24, 2023
DSLD ID 298568
Product type Other Combinations
Supplement form Tablet Or Pill
Dietary claims / uses Nutrient, All Other, Structure/Function
Intended target group(s) Children 4 or More Years of Age, Gluten Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Pedi-Active Delicious Mixed Berry Flavor by NaturesPlus, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
2 Chewable Tablet(s)
Maximum serving Sizes:
2 Chewable Tablet(s)
Servings per container
60
UPC/BARCODE
097467030015
IngredientAmount% DV
Calories5 Calorie(s)--
Total Carbohydrates2 Gram(s)1%
Sugar2 Gram(s)--
Phosphatidylserine20 mg--
DMAE100 mg--
Phosphatidylcholine20 mg--
Phosphatidylserine-rich purified Soy Lecithin concentrate100 mg--
Cephalin12 mg--
Phosphoinositides6 mg--

Other ingredients: Fructose, Stearic Acid, natural Berry flavors, Silica, Magnesium Stearate, Beet Juice

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula

Pedi-Active is a precisely calibrated formula designed for the active child. Each incredibly delicious, chewable tablet supplies a profile of the most advanced neuronutrients available. With a diversified, highly specialized combination of phosphatidylserine, DMAE and activated soy phosphatides, including phosphatidylcholine, each Pedi-Active tablet is a state-of-the-art nutritional supplement that naturally complements an active child's delicate system.

Formulation

Free from artificial colors and preservatives.

Gluten free

Suggested/Recommended/Usage/Directions

Directions: As a dietary supplement, two chewable tablets three to four times daily or as recommended by your health care professional.

Storage

Keep tightly closed in a cool, dry place.

Precautions

Keep out of reach of children.

FDA Disclaimer Statement

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

FDA Statement of Identity

Phosphatidylserine/DMAE Supplement for Active Children

Brand IP Statement(s)

Copyright Natural Organics

See for yourself

Pedi-Active Delicious Mixed Berry Flavor by NaturesPlus label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Pedi-Active Delicious Mixed Berry Flavor by NaturesPlus

These are the 3 active ingredients this product is made of. Select any to open its full monograph.

Serving size2 Chewable Tablet(s) Dosage formTablet Or Pill Servings per container60 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Sugar

2 Gram(s) per serving

DMAE

Interacts with
219 drugs
100 mg per serving Form: 2-Dimethylaminoethanol Bitartrate

Deanol (DMAE) is a compound related to choline that is marketed for memory, focus, and mood, but solid human evidence for most of these uses is limite...

DMAE monograph & interactions
100 mg per serving

Lecithin is a natural fatty substance found in foods and made by the body that is widely used as a supplement and food emulsifier. Evidence supporting...

Phosphatidylserine-rich purified Soy Lecithin concentrate monograph & interactions

Other (inactive) ingredients: Fructose, Stearic Acid, Natural Berry flavors, Silica, Magnesium Stearate, Beet Juice. These complete the product’s ingredient list but are not active constituents.

Interaction report

Pedi-Active Delicious Mixed Berry Flavor by NaturesPlus Drug Interactions

Want to check YOUR meds against Pedi-Active Delicious Mixed Berry Flavor?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
219Drugs
219 Moderate

Ingredients driving the most interactions

DMAE 219

Each ingredient & the kinds of drugs it affects

For each ingredient in Pedi-Active Delicious Mixed Berry Flavor with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

DMAE2 drug types · 219 drugs

Anticholinergic Drugs

Theoretically, deanol might decrease the effectiveness of anticholinergic drugs.
Deanol is thought to increase acetylcholine levels.

Likelihood Unlikely Evidence D
Cholinergic Drugs

Theoretically, deanol might increase the effects and adverse effects of cholinergic drugs.
Deanol is thought to increase acetylcholine levels.

Likelihood Unlikely Evidence D
The maker

Brand information

Manufacturer and brand details for Pedi-Active Delicious Mixed Berry Flavor, from the product label.

NaturesPlus

See all NaturesPlus products
Name
Natural Organics Laboratories Inc. makers of Nature's Plus
Street Address
9500 New Horizons Blvd.
City
Amityville
State
NY
ZipCode
11701
Web Address
www.naturesplus.com
Pharmacist Counseling Corner

Pedi-Active Delicious Mixed Berry Flavor by NaturesPlus: Common Questions

Does Pedi-Active Delicious Mixed Berry Flavor by NaturesPlus interact with any medications?
Yes. Based on its ingredients, Pedi-Active Delicious Mixed Berry Flavor has a known interaction with 219 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Pedi-Active Delicious Mixed Berry Flavor contains 3 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is this safe for my child during pregnancy?
No—this product is not recommended during pregnancy. Phosphatidylserine and DMAE lack sufficient safety data and should be avoided. While phosphatidylcholine contains choline (which is needed in pregnancy), supplement safety beyond food sources isn't well established. Talk with your doctor before use.
Can I give this while breastfeeding?
Safety data for breastfeeding is not available for these ingredients, so avoidance is recommended. Speak with your healthcare provider first.
What are the most common side effects?
For phosphatidylserine: flatulence, stomach upset, headache, insomnia, and nausea. For phosphatidylcholine: bloating, diarrhea, altered taste, nausea, vomiting, and increased sweating. For DMAE: abdominal cramps and pain, diarrhea, drowsiness, nausea, and vomiting. Side effects are generally mild, but high doses raise the risk.
Does this really help with ADHD?
The evidence isn't established. Phosphatidylserine is rated as having insufficient reliable evidence for ADHD, and DMAE is also rated insufficient—we don't have strong data showing it works for this purpose.
Can my child take this with their allergy medication?
Many allergy medications are anticholinergics, which can interact with phosphatidylserine and DMAE in this product. Use the search tool on this page to check your child's exact medication before starting, and confirm with your pediatrician or pharmacist.
What is DMAE for?
DMAE is a compound believed to affect neurotransmitter levels in the brain. However, research shows it is likely ineffective for Alzheimer disease and tardive dyskinesia, and evidence is insufficient for other uses like ADHD or athletic performance.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Pedi-Active Delicious Mixed Berry Flavor is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Pedi-Active Delicious Mixed Berry Flavor label
Sources

Sources & How We Checked

Pedi-Active Delicious Mixed Berry Flavor's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 48 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Phosphatidylserine 9 references
  1. Crook T, Petrie W, Wells C, Massari DC. Effects of phosphatidylserine in Alzheimer's disease. Psychopharmacol Bull 1992;28:61-6.
  2. Pepping J. Phosphatidylserine. Am J Health-Syst Pharm 1999;56:2038,2043-4.
  3. Kidd PM. Phosphatidylserine; Membrane nutrient for memory. A clinical and mechanistic assessment. Altern Med Rev 1996;1:70-84.
  4. Kim HY, Akbar M, Lau A, et al. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000;275:35215-23.. PubMed
  5. Zanotti A, Valzelli L, Toffano G. Chronic phosphatidylserine treatment improves spatial memory and passive avoidance in aged rats. Psychopharmacology (Berl) 1989;99:316-21.. PubMed
  6. Schreiber S, Kampf-Sherf O, Gorfine M, et al. An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci 2000;37:302-7.
  7. Pepping, J. Phosphatidylserine. Am J Health Syst.Pharm. 10-15-1999;56(20):2038, 2043-2038, 2044.
  8. Monteverde, A., Gnemmi, P., Rossi, F., Monteverde, A., and Finali, G. C. Selegiline in the treatment of mild to moderate Alzheimer-type dementia. Clin.Ther 1990;12(4):315-322.
  9. Vakhapova V, Cohen T, Richter Y, Herzog Y, Kam Y, Korczyn AD. Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study. Dement Geri PubMed

See these in context on the Phosphatidylserine monograph →

Deanol 15 references
  1. Davies C, Maidment S, Hanley P, et al. Dimethylaminoethanol (DMAE). HSE. Risk assessment document; EH72/2;1997. (TOXLINE).
  2. Re O. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Ther Res Clin Exp 1974;16:1238-42.
  3. Pieralisi G, Ripari P, Vecchiet L. Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance during exercise. Clin Ther 1991;13:373-82.
  4. George J, Pridmore S, Aldous D. Double blind controlled trial of deanol in tardive dyskinesia. Aust N Z J Psychiatry 1981;15:68-71. PubMed
  5. Penovich P, Morgan JP, Kerzner B, et al. Double-blind evaluation of deanol in tardive dyskinesia. JAMA 1978;239:1997-8. DOI
  6. de Montigny C, Chouinard G, Annable L. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study. Psychopharmacology (Berl) 1979;65:219-23. PubMed
  7. Lindeboom SF, Lakke JP. Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias. Acta Neurol Scand 1978;58:134-8. PubMed
  8. Jus A, Villeneuve A, Gautier J, et al. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study. Neuropsychobiology 1978;4:140-9. PubMed
  9. Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin Pharmacol Ther 1975;17:534-40. PubMed
  10. Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease. Am J Psychiatry 1981;138:970-2. PubMed
  11. Ferris SH, Sathananthan G, Gershon S, et al. Senile dementia: treatment with deanol. J Am Geriatr Soc 1977;25:241-4. PubMed
  12. Haug BA, Holzgraefe M. Orofacial and respiratory tardive dyskinesia: potential side effects of 2-dimethylaminoethanol (deanol)? Eur Neurol 1991;31:423-5. PubMed
  13. Casey DE. Mood alterations during deanol therapy. Psychopharmacology (Berl) 1979;62:187-91. PubMed
  14. Sergio W. Use of DMAE (2-dimethylaminoethanol) in the induction of lucid dreams. Med Hypotheses 1988;26:255-7. PubMed
  15. Osol A, Hoover JE, eds. Remington's Pharmaceutical Science, 15th ed. Easton, PA: Mack Publishing Company, 1975.

See these in context on the Deanol monograph →

Phosphatidylcholine 15 references
  1. Domino EF, May WW, Demetriou S, et al. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy. Biol Psychiatry 1985;20:1189-96. PubMed
  2. Aronson PJ, Lorincz AL. Promotion of palmar sweating with oral phosphatidylcholine. Acta Derm Venereol 1985;65:19-24. DOI
  3. Hexsel DM, Serra M, de Oliveira Dal'Forno T, et al. Cosmetic uses of injectable phosphatidylcholine on the face. Otolaryngol Clin North Am 2005;38:1119-29. PubMed
  4. Kopera D, Binder B, Toplak H, et al. Histopathologic changes after intralesional application of phosphatidylcholine for lipoma reduction: report of a case. Am J Dermatopathol 2006;28:331-3. PubMed
  5. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 2001;27:391-2. PubMed
  6. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 2006;32:465-80. PubMed
  7. Hexsel D, Serra M, Mazzuco R, et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003;2:511-8.
  8. Hasengschwandtner F. Phosphatidylcholine treatment to induce lipolysis. Cosmet Dermatol 2005;4:308-13. PubMed
  9. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast Surg 2003;27:315-8. PubMed
  10. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg 2004;30:422-7. PubMed
  11. Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med 2012;52(9):1658-65. PubMed
  12. Panos, J. M., Palson, R., Johnson, R., Portmann, B., and Williams, R. Polyunsaturated phosphatidylcholine for acute alcoholic hepatitis: a double blind randomized placebo controlled trial. Eur.J.Gastroenterol 1990;2:351-355.
  13. Stremmel W, Braun A, Hanemann A, Ehehalt R, Autschbach F, Karner M. Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study. J Clin Gastroenterol 2010;44(5):e101-7. PubMed
  14. Stremmel W, Ehehalt R, Autschbach F, Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med. 2007;147(9):603-10. PubMed
  15. Stremmel W, Vural H, Evliyaoglu O, Weiskirchen R. Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis. Dig Dis 2021;39(5):508-515. PubMed

See these in context on the Phosphatidylcholine monograph →

Lecithin 9 references
  1. Buchman AL, Dubin M, Jenden D, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 1992;102:1363-70.
  2. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (2000). Washington, DC: National Academy Press, 2000. Available at: http://b
  3. Chatellier G, Lacomblez L. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine. BMJ 1990;300:495-9.
  4. Gelenberg AJ, Dorer DJ, Wojcik JD, et al. A crossover study of lecithin treatment of tardive dyskinesia. J Clin Psychiatry 1990;51:149-53.
  5. Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985;48:736-42. PubMed
  6. Palm M, Moneret-Vautrin DA, Kanny G, et al. Food allergy to egg and soy lecithins. Allergy 1999;54:1116-7. PubMed
  7. Drachman DA, Glosser G, Fleming P, et al. Memory decline in the aged: treatment with lecithin and physostigmine. Neurology 1982;32:944-50. PubMed
  8. Gelenberg, A. J., Doller-Wojcik, J. C., and Growdon, J. H. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry 1979;136(6):772-776. PubMed
  9. Electronic Code of Federal Regulations. Title 21, Chapter 1, Subchapter B, Part 184: Direct food substances affirmed as Generally Recognized as Safe. Subpart B - listing of specific substances affirmed as GRAS. Sec. 184.1400 Lecithin. Available at: https:

See these in context on the Lecithin monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring